BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6435673)

  • 1. The effect of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene on human blood platelet structural physiology.
    Lasslo A; White JG
    Biochim Biophys Acta; 1984 Oct; 777(1):37-40. PubMed ID: 6435673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic ionized calcium in human platelets: the influence of collagen and a novel antiplatelet agent.
    Gollamudi R; Dillingham EO; Bond SE; Lyman BA
    Biochem Biophys Res Commun; 1991 Jun; 177(2):888-93. PubMed ID: 2049109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide.
    Lyman BA; Bond SE; Dillingham EO; Lawrence WH; Gollamudi R
    Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):279-88. PubMed ID: 1475529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.
    Herron D; Dillingham EO; Lyman BA; Zheng X; Bond SE; Salgia SR; Gollamudi R
    Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):309-18. PubMed ID: 7630919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.
    Han G; Bannerman D; Handa RK; Dillingham EO; Lawrence WH; Gollamudi R
    Gen Pharmacol; 1997 Apr; 28(4):617-21. PubMed ID: 9147034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic nipecotamide increases cyclic AMP levels and inhibits protein phosphorylation in human platelets.
    Handa RK; Dillingham EO; Gollamudi R
    Life Sci; 1995; 57(10):983-8. PubMed ID: 7643723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective antiplatelet actions of nipecotamides.
    Gollamudi R; Feng Z; Dillingham EO; Bond SE; Han G; Salgia S
    Thromb Res; 1993 Feb; 69(4):361-7. PubMed ID: 8470057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary in vivo studies on the platelet aggregation inhibitory activity of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide in beagle dogs.
    Lawrence WH; Gollamudi R; Dillingham EO; Carter-Burks G; Tisdelle PA; Lasslo A
    J Pharm Sci; 1988 May; 77(5):464-5. PubMed ID: 3411473
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of thrombus formation in vivo by novel antiplatelet agent.
    Marzec UM; Kelly AB; Hanson SR; Lasslo A; Harker LA
    Arteriosclerosis; 1990; 10(3):367-71. PubMed ID: 2140503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization of vasopressin-like material in platelets.
    Chesney CM; Crofton JT; Pifer DD; Brooks DP; Huch KM; Share L
    J Lab Clin Med; 1985 Sep; 106(3):314-8. PubMed ID: 3928782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vernolepin: an antiplatelet compound of natural origin.
    Laekeman GM; De Clerck F; Vlietinck AJ; Herman AG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):108-13. PubMed ID: 3934564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release.
    Egger M; Donath E; Spangenberg P; Bimmler M; Glaser R; Till U
    Biochim Biophys Acta; 1988 Dec; 972(3):265-76. PubMed ID: 3143424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyltin compounds in vitro inhibition of human platelet epinephrine-induced aggregation and blockade of epinephrine binding to platelets.
    Yanagisawa H; Wada O
    Ind Health; 1985; 23(4):255-68. PubMed ID: 3938784
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of heparin on platelet aggregation in vitro].
    RĂ³ka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of scanning electron microscopy to study structural-functional relationships in normal and diseased platelets.
    Mattson JC
    Scan Electron Microsc; 1985; (Pt 1):357-91. PubMed ID: 3890145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fish oil: a potent inhibitor of platelet adhesiveness.
    Li XL; Steiner M
    Blood; 1990 Sep; 76(5):938-45. PubMed ID: 2118400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet storage pool deficiency of alpha and delta granules.
    Biddle DA; Neto TG; Nguyen AN
    Arch Pathol Lab Med; 2001 Aug; 125(8):1125-6. PubMed ID: 11473478
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of phosphorylation/dephosphorylation reactions in the function of blood platelets.
    Gerrard JM; Beattie LL; Israels SJ; Park J
    Agents Actions Suppl; 1986; 20():129-45. PubMed ID: 3101441
    [No Abstract]   [Full Text] [Related]  

  • 20. A variant form of thrombasthenia.
    Tarantino MD; Corrigan JJ; Glasser L; Payne CM; Jeter MA
    Am J Dis Child; 1991 Sep; 145(9):1053-7. PubMed ID: 1908636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.